Europe

View All
April 28, 2022 Off

Vifor-Cara Therapeutics’s Kapruvia Approved for Treatment of Moderate-to-Severe Pruritus in Hemodialysis in EU

By Author

Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics have announced that the European Commission has granted marketing authorization to Kapruvia (difelikefalin) for the treatment of moderate-to-severe pruritus associated with...

USA

View All
April 29, 2022 Off

FDA Approves BMS’s Camzyos for the Treatment of Adults With Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM)

By Author

Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Camzyos™ (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules) for the treatment...

My Pharmaceutical

View All
April 13, 2022 Off

Allergan’s BOTOX Cosmetic Celebrates 20th Birthday

By Author

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating 20th anniversary of FDA's approval of Botox Cosmetic.

April 13, 2022 Off

EMA and the EUnetHTA 21 consortium set priorities for their collaboration

By Author

The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) 21 consortium have published a  joint work plan until 2023....

April 4, 2022 Off

Sanofi Launches First-In-Pharma Diversity, Equity & Inclusion Board

By Author

Sanofi has launched its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors....